CSIMarket
 
Ispecimen inc   (ISPC)
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 

Slight -4.97 %, revenue slide at Ispecimen Inc in the financial three months closing Sep 30 2022

Ispecimen Inc recorded third quarter of 2022 operating loss of $-3.101059 million


Published 2022-11-10T12:52:01+00:00
Goran Soko / CSIMarket.com Contributer


dna-163466__340Lower revenue led to diminishing Returns in the fiscal period ending September 30 2022, Revenue fell by -4.97 % to $2.58 million and deficit per share was at $-0.35 in proportion to $-0.22 per share realized in the quarter a year ago.

Looking into earnings from the preceding quarter revenue advanced by 10.464 % from $2.34 million and increased deficit from $-0.30 per share.


For the fiscal period ending September 30 2022 Ispecimen Inc realized net deficit of $-3.096 million, bigger than $-1.553 million a year ago.


Ispecimen Inc is expected to report next financial earnings on August 03, 2023.



Ispecimen Inc's Effective Tax Rate

Ispecimen Inc's Income per Employee



Other ISPC's Earnings Reports








Other ISPC's Earnings Reports








Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071